Prescription drug spending trends for the privately insured in Maryland, 2000-2001

Health Affairs
Fadia T ShayaC Daniel Mullins

Abstract

Out-of-pocket drug spending per patient rose 25 percent in 2001 for the privately insured nonelderly in Maryland, outpacing the 10 percent increase in total drug spending per patient. Prescription drug use patterns changed little in response to a 30 percent rise in copayments, with the number of prescriptions per patient decreasing by 3 percent, and the proportion of generic drugs remaining steady. About 23 percent of patients spent less than 50 dollars on drugs in 2001, while 21 percent spent more than 700 dollars. Findings suggest that a greater proportion of the economic burden of prescription drugs in coming years will be borne by those who use them.

References

Mar 10, 2001·JAMA : the Journal of the American Medical Association·R TamblynL Mallet
Mar 15, 2002·The New England Journal of Medicine·Sebastian SchneeweissStephen B Soumerai
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Donald M Steinwachs
Jan 17, 2003·Health Affairs·Katharine LevitAaron Catlin
Mar 9, 2004·Health Affairs·Sachin Kamal-Bahl, Becky Briesacher

❮ Previous
Next ❯

Citations

May 13, 2009·PLoS Medicine·Susan Chimonas, Jerome P Kassirer
Mar 7, 2012·American Journal of Public Health·Joan M O'ConnellKelly J Acton
Aug 1, 2006·Emergency Medicine Clinics of North America·Hal Minnigan, Carey D Chisholm
Jun 23, 2006·Social Science & Medicine·Joanna Kempner
May 17, 2007·The Annals of Pharmacotherapy·Daniel M HartungRoger Chou
Mar 16, 2017·Nature Reviews. Clinical Oncology·Vinay PrasadSham Mailankody
Dec 29, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Michael T Mueller, Alexander Frenzel
Mar 7, 2012·Pharmacotherapy·J Russell Teagarden, Eric J Stanek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Meredith B RosenthalArnold M Epstein
The New England Journal of Medicine
J K Iglehart
BMJ : British Medical Journal
J D RamsdenM Witham
© 2021 Meta ULC. All rights reserved